Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] - N0000182639

Pharmacologic Class Information

Pharmacologic Code N0000182639
Pharmacologic Name Hepatitis C Virus NS3/4A Protease Inhibitor
Pharmacologic Uses
  • hepatitis C virus (HCV) NS3/4A protease inhibitor
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Hepatitis C Virus NS3/4A Protease Inhibitor

The table contains 4 products whose active ingredient are classified under the same pharmacologic class Hepatitis C Virus NS3/4A Protease Inhibitor [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0006-3074Zepatier Non-Proprietary Name: Elbasvir And GrazoprevirTablet, Film CoatedOralMerck Sharp & Dohme LlcACTIVE
0074-2600Mavyret Non-Proprietary Name: Glecaprevir And PibrentasvirPelletOralAbbvie Inc.ACTIVE
0074-2625Mavyret Non-Proprietary Name: Glecaprevir And PibrentasvirTablet, Film CoatedOralAbbvie Inc.ACTIVE
61958-2401Vosevi Non-Proprietary Name: Sofosbuvir, Velpatasvir, And VoxilaprevirTablet, Film CoatedOralGilead Sciences, Inc.ACTIVE